| Immunogenicity of Fractional Dose of the HPV Vaccines (NCT05291871) | University of Washington | 2022-06-15 |
| A Phase III Clinical Trial of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Women Aged 9-45 Years (NCT05262010) | National Vaccine and Serum Institute, China | 2022-06-04 |
| Effect of HPV Integration on Prognosis of Young Women With CIN2 in China (NCT05282095) | Fujian Maternity and Child Health Hospital | 2022-06-01 |
| Psycho-emotional Impact of Preoperative Counselling in Cervico-carcinoma Screening Programs (NCT06500767) | University of Turin, Italy | 2022-06-01 |
| Effectiveness of the Q-HPV Vaccine 9-years Post Vaccination Among HIV Positive Adolescents (NCT05435209) | University of Washington | 2022-05-25 |
| Identification and Treatment of Cervical Abnormalities in Perú Through Integration of Pocket Colposcopy and Telemedicine (NCT05340322) | Duke University | 2022-05-01 |
| Acceptability of HPV Self-sampling Among Canadian Women Aged 21 to 65 (NCT05414929) | Université de Sherbrooke | 2022-04-04 |
| HPV Vaccination in HIV Infected and HIV Uninfected Adolescents in Eswatini (NCT04982614) | Columbia University | 2022-04-01 |
| The Organ Transplant Recipient HPV and Skin Cancer Study (NCT05284877) | Merete Haedersdal | 2022-03-10 |
| Research About Impact of HPV Integration on the Prognosis of Women With Persistent HR-HPV Infection (NCT05283239) | Fujian Maternity and Child Health Hospital | 2022-01-01 |
| Clinical Evaluation of HPV Integration Triage for Detection of Cervical Precancer in HPV-positive Women (NCT05570331) | Ding Ma | 2022-01-01 |
| A Multicenter Cohort Study of HPV Viral Load in Predicting the Postoperative Recurrence of HSIL (NCT05282745) | Fujian Maternity and Child Health Hospital | 2021-12-15 |
| HPV Viral Load in Predicting the Prognosis of LSIL (NCT05051852) | Fujian Maternity and Child Health Hospital | 2021-09-01 |
| HPV Vaccine in Postpartum Women (NCT04430907) | Milton S. Hershey Medical Center | 2021-09-01 |
| Characteristics of Vaginal and Intestinal Microbiota and Cervical HPV Infection (NCT05003505) | Fujian Maternity and Child Health Hospital | 2021-07-01 |
| "Lactobacillus Crispatus M247, LSIL and Microbiota" (NCT05808816) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2021-06-16 |
| Concomitant HPV Vaccination and HPV Screening HPV Infection and Cervical Cancer in Sweden (NCT04910802) | Miriam Elfström | 2021-05-03 |
| Lot Consistency Clinical Trial of Bivalent HPV Vaccine in 9 to 30 Years Old Healthy Females (NCT04965350) | Shanghai Zerun Biotechnology Co.,Ltd | 2021-04-20 |
| BS-FU01 Follow-Up Study of FluBHPVE6E7 Study Subjects (NCT04528407) | BlueSky Immunotherapies GmbH | 2021-04-09 |
| Prime-boost Vaccine Study in Women With Low-grade Cervical HPV Lesions (NCT04607850) | Barinthus Biotherapeutics | 2021-03-16 |
| Evaluation of the Prevalence of Oral HPV Infection in Patients Who Are Positive to the PAP-test (NCT05949398) | University of Catania | 2021-03-01 |
| Nine-valent HPV Vaccine to Prevent Persistent Oral HPV Infection in Men Living With HIV (NCT04255849) | Weill Medical College of Cornell University | 2021-02-23 |
| Study of FluBHPVE6E7 in HPV-16 Infected Women (NCT04490512) | BlueSky Immunotherapies GmbH | 2020-12-09 |
| HPV Vaccination Health-promotion Programme on Vaccine Acceptance and Uptake Among Female Adolescents (NCT04438291) | Chinese University of Hong Kong | 2020-12-01 |
| Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial (NCT04679675) | Kaiser Permanente | 2020-11-20 |
| Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3) (NCT04098744) | Frantz Viral Therapeutics, LLC | 2020-09-09 |
| Nabothian Cyst Protects or Facilitates Against Cervical Cancer (NCT04488991) | Haseki Training and Research Hospital | 2020-07-23 |
| HPV-Based Screen-and-Treat Demonstration Project in Lilongwe (NCT04092257) | UNC Lineberger Comprehensive Cancer Center | 2020-06-24 |
| Immunogenicity AND Safety Study of the 11 Valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) (NCT04436133) | National Vaccine and Serum Institute, China | 2020-06-20 |
| HPV Prevalence in 16-20 Year Old Males (NCT04297670) | Laval University | 2020-02-20 |
| Immunogenicity and Safety of a 9-valent Human Papillomavirus Vaccine in HIV-positive Women (NCT04270773) | University Hospital Virgen de las Nieves | 2020-02-12 |
| Retrospective Cohort Study of the Effectiveness of the Prophylactic Vaccine Against the Human Papilloma Virus in the Prevention of Recurrence in Women Who Have Received an Excisional Therapy by HSIL / CIN. (NCT04171505) | Hospital San Carlos, Madrid | 2019-11-04 |
| Re-Evaluation of Annual Cytology Using HPV Testing to Upgrade Prevention in Women Living With HIV (NCT04155294) | University of Oxford | 2019-10-28 |
| The Study for the "Cervical Cancer Screening and Treatment Algorithms Study Using HPV Testing in Africa" (NCT04794660) | International Agency for Research on Cancer | 2019-10-01 |
| Thermocoagulation for Treatment of Precancerous Cervical Lesions (NCT04191967) | University of California, San Francisco | 2019-09-25 |
| A Randomized, Blinded, Placebo-controlled Phase I Clinical Trial Evaluating the Safety and Preliminary Immunogenicity of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Women Aged 9-45 Years (NCT04083196) | National Vaccine and Serum Institute, China | 2019-09-07 |
| Therapeutic Abstention and Surveillance of Intra-epithelial Histological Lesions of High Grade Cervical CIN2 (Cervical Intraepithelial Neoplasia Grade 2). SUIVICIN (NCT04057924) | University Hospital, Bordeaux | 2019-08-23 |
| Human Papilloma Virus (HPV) Self-collection and Women Adherence (NCT05059015) | Instituto Nacional de Cancerologia, Columbia | 2019-05-01 |
| Clinical Trial to Evaluate Papilocare® Gel Efficacy Into Repairment of Cervical Lesions Caused by HPV (NCT04210336) | Procare Health Iberia S.L. | 2018-08-07 |
| Investigation to Evaluate PAPILOCARE® Gel Effect on Normalization of Cervix Cytological Alterations Caused by HPV. (NCT04199260) | Procare Health Iberia S.L. | 2018-05-20 |
| A Pilot Study on HPV and Cervical Cancer Screening in Mumbai (NCT03229603) | Tata Memorial Hospital | 2018-04-01 |
| Probiotics Role in HPV Cervico-vaginal Infection Clearance (NCT05109533) | Azienda Ospedaliero, Universitaria Pisana | 2018-01-01 |
| Antibody Response to Prophylactic QHPV Vaccine at 48 Months Among HIV-infected Girls and Boys (NCT04711265) | Kenya Medical Research Institute | 2015-09-01 |
| Yallaferon in Chinese Population (NCT02593968) | Lee's Pharmaceutical Limited | 2015-09-01 |
| A New Supplement for the Immune Response to HPV Infection (NCT02263378) | University of Messina | 2014-09-01 |
| HPV Genotyping by DR. HPV Genotyping in Vitro Diagnostic Device (IVD) Kit in Exfoliated Cells of the Uterine Cervix (NCT04333212) | Chang Gung Memorial Hospital | 2012-12-12 |
| Epidemiology of High-risk HPV Infection in Women Participating in a Pilot Screening Program for Cervical Cancer (NCT02809352) | CHU de Reims | 2012-07-01 |
| Human Papillomavirus Anal Infection (NCT02862795) | Centre Hospitalier Universitaire de Besancon | 2012-04-01 |
| Human Papillomavirus Infection and Knowledge and Attitudes About HPV Vaccines Among Men Who Have Sex With Men (MSM) (NCT01300689) | Chinese Academy of Medical Sciences | 2011-07-01 |
| HPV in Adolescents (NCT01788852) | The HIV Netherlands Australia Thailand Research Collaboration | 2010-12-01 |
| Polyhexamethylene Biguanide Increases the Regression Rate of Human Papillomavirus (HPV) Infection (NCT01571141) | AGUNCO Obstetrics and Gynecology Centre | |